MedPath

Azithromycin

Azithromycin for Oral Suspension USP 7148 7149 Rx only

Approved
Approval ID

4e9ac94f-4d85-4731-8b7f-6188209b4a9c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 16, 2013

Manufacturers
FDA

MedVantx, Inc.

DUNS: 806427725

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azithromycin Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66116-524
Application NumberANDA065419
Product Classification
M
Marketing Category
C73584
G
Generic Name
Azithromycin Monohydrate
Product Specifications
Route of AdministrationORAL
Effective DateMay 16, 2013
FDA Product Classification

INGREDIENTS (10)

AZITHROMYCIN MONOHYDRATEActive
Quantity: 200 mg in 5 mL
Code: JTE4MNN1MD
Classification: ACTIM
ETHYL VANILLINInactive
Code: YC9ST449YJ
Classification: IACT
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATEInactive
Code: B70850QPHR
Classification: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2D
Classification: IACT
VANILLINInactive
Code: CHI530446X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Azithromycin - FDA Drug Approval Details